Description

5-Ethyl-9-[3-(p-Chlorobenzoyl)Propyl]-1-Oxa-3,9-Diazaspiro[5.5]Undecan-2-One is a high-purity, complex organic compound featuring a spirocyclic structure, which is of significant interest in advanced pharmaceutical research and development. This compound serves as a critical pharmaceutical intermediate or active pharmaceutical ingredient (API) building block, enabling the synthesis of novel therapeutic agents. It is primarily needed by R&D laboratories, custom synthesis providers, and pharmaceutical manufacturers focused on developing new drugs, particularly in the central nervous system (CNS) and other therapeutic areas.

Application

• Pharmaceutical Intermediate: A key building block in the multi-step synthesis of novel active pharmaceutical ingredients (APIs).
• Drug Discovery & Research: Used in medicinal chemistry programs for structure-activity relationship (SAR) studies and lead optimization.
• Custom Synthesis: Serves as a starting material or advanced intermediate for contract research and manufacturing organizations (CRAMOs).
• Reference Standard: Employed as an analytical standard for quality control and method development in pharmaceutical analysis.
• Biochemical Research: Utilized in studies investigating specific biological pathways and receptor interactions.

Basic Information

Item	Details
Product Name	5-Ethyl-9-[3-(p-Chlorobenzoyl)Propyl]-1-Oxa-3,9-Diazaspiro[5.5]Undecan-2-One
CAS No.	54981-21-4
Molecular Formula	C22H31ClN2O3
Molecular Weight	406.95 g/mol
Synonyms	5-Ethyl-9-[3-(4-chlorobenzoyl)propyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one; 1-Oxa-3,9-diazaspiro[5.5]undecan-2-one, 5-ethyl-9-[3-(4-chlorobenzoyl)propyl]-; CAS 54981-21-4; UNII-9K8V7JQ49D; 9K8V7JQ49D; Spirocyclic benzamide derivative; p-Chlorobenzoyl propyl substituted oxadiazaspiro compound
EINECS	Contact for details

Quality Control

Our 5-Ethyl-9-[3-(p-Chlorobenzoyl)Propyl]-1-Oxa-3,9-Diazaspiro[5.5]Undecan-2-One is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. Certificates of Analysis (COA) documenting full specifications are available for every lot. We support compliance with cGMP and ICH guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity	≤ 0.5%
Total Impurities	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.